TR200100014T2 - Mukozal patolojilerin topikal tedavisinde kullanıma yönelik E vitamini - Google Patents

Mukozal patolojilerin topikal tedavisinde kullanıma yönelik E vitamini

Info

Publication number
TR200100014T2
TR200100014T2 TR2001/00014T TR200100014T TR200100014T2 TR 200100014 T2 TR200100014 T2 TR 200100014T2 TR 2001/00014 T TR2001/00014 T TR 2001/00014T TR 200100014 T TR200100014 T TR 200100014T TR 200100014 T2 TR200100014 T2 TR 200100014T2
Authority
TR
Turkey
Prior art keywords
proctitis
vitamin
vulvitis
treatment
mucosa
Prior art date
Application number
TR2001/00014T
Other languages
English (en)
Turkish (tr)
Inventor
Panin Giorgio
Annunziata Eleonora
Original Assignee
Panin Giorgio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200100014(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Panin Giorgio filed Critical Panin Giorgio
Publication of TR200100014T2 publication Critical patent/TR200100014T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
TR2001/00014T 1998-07-10 1999-07-05 Mukozal patolojilerin topikal tedavisinde kullanıma yönelik E vitamini TR200100014T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose

Publications (1)

Publication Number Publication Date
TR200100014T2 true TR200100014T2 (tr) 2001-06-21

Family

ID=11380415

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/00014T TR200100014T2 (tr) 1998-07-10 1999-07-05 Mukozal patolojilerin topikal tedavisinde kullanıma yönelik E vitamini
TR2001/03710T TR200103710T2 (tr) 1998-07-10 1999-07-05 Vajinal mukozayı etkileyen patolojilerin topikal tedavisinde kullanıma yönelik E vitamini

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2001/03710T TR200103710T2 (tr) 1998-07-10 1999-07-05 Vajinal mukozayı etkileyen patolojilerin topikal tedavisinde kullanıma yönelik E vitamini

Country Status (22)

Country Link
EP (1) EP1094807B1 (enExample)
JP (1) JP2002520281A (enExample)
CN (1) CN1135975C (enExample)
AT (1) ATE238051T1 (enExample)
AU (1) AU762860B2 (enExample)
BR (1) BR9911945A (enExample)
CA (1) CA2336990A1 (enExample)
CZ (1) CZ301019B6 (enExample)
DE (1) DE69907193T2 (enExample)
DK (1) DK1094807T3 (enExample)
ES (1) ES2196813T3 (enExample)
HU (1) HU228921B1 (enExample)
IL (1) IL140759A0 (enExample)
IT (1) ITMI981586A1 (enExample)
NO (1) NO20006719L (enExample)
NZ (1) NZ509129A (enExample)
PL (1) PL345500A1 (enExample)
PT (1) PT1094807E (enExample)
RU (2) RU2221561C2 (enExample)
SK (1) SK284464B6 (enExample)
TR (2) TR200100014T2 (enExample)
WO (1) WO2000002554A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
RU2428973C2 (ru) * 2005-03-03 2011-09-20 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие липидопонижающими свойствами
JP5731980B2 (ja) * 2008-10-09 2015-06-10 ラムズコア, インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
RU2540481C2 (ru) * 2009-07-27 2015-02-10 Сальваторе Троизи Офтальмологический раствор для защиты внутренних структур глазного яблока от уф-а лучей или для лечения кератоконуса методом трансэпителиального кросс-линкинга
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
LT3209294T (lt) * 2014-10-22 2019-10-25 Bio Lo Ga Srl Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンe点眼剤
JP3551977B2 (ja) * 1993-04-08 2004-08-11 ライオン株式会社 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
EP1094807B1 (en) 2003-04-23
ITMI981586A1 (it) 2000-01-10
ATE238051T1 (de) 2003-05-15
NZ509129A (en) 2003-10-31
PL345500A1 (en) 2001-12-17
SK352001A3 (en) 2001-06-11
HUP0102781A2 (hu) 2001-12-28
PT1094807E (pt) 2003-08-29
RU2003128023A (ru) 2005-04-10
DK1094807T3 (da) 2003-08-11
JP2002520281A (ja) 2002-07-09
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
AU4385899A (en) 2000-02-01
EP1094807A1 (en) 2001-05-02
CN1308531A (zh) 2001-08-15
BR9911945A (pt) 2001-03-27
IL140759A0 (en) 2002-02-10
DE69907193D1 (de) 2003-05-28
AU762860B2 (en) 2003-07-10
ES2196813T3 (es) 2003-12-16
DE69907193T2 (de) 2004-04-08
CZ200136A3 (cs) 2001-08-15
CN1135975C (zh) 2004-01-28
NO20006719D0 (no) 2000-12-29
CZ301019B6 (cs) 2009-10-14
HU228921B1 (en) 2013-06-28
ITMI981586A0 (it) 1998-07-10
RU2221561C2 (ru) 2004-01-20
NO20006719L (no) 2001-02-16
TR200103710T2 (tr) 2002-06-21
CA2336990A1 (en) 2000-01-20
HUP0102781A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
PL345500A1 (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
HN1999000045A (es) Derivados biciclicos del acido hidroxamico
DK1296670T3 (da) Terapeutiske fedtsyrekombinationer
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
DE50205928D1 (de) Hysteroskop mit Wechselschaftsystem
AR018194A1 (es) Formulaciones para la prevencion o el tratamiento de enfermedades que afectan la mucosa o la piel, o para la prevencion de embarazo, y una aplicacion parala administracion de formulaciones topicas dentro de las cavidades mucosales
CY1109328T1 (el) Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου
JP2005532350A5 (enExample)
DK1494629T3 (da) Præservativ
ATE360428T1 (de) Analgetisches arzneimittel
USD505493S1 (en) Ovulation scope
HUP0104652A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása öregkori szervi rendellenességek és öregkori betegségek megakadályozására és az élet meghosszabbítására alkalmas gyógyszerkészítmények előállítására
DK1105141T3 (da) Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
UA68381C2 (en) Spermicidal substance and vaginal contraceptive
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
WO1999058107A8 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
CA2287107A1 (en) Device for removing pathological centers in human and veterinary medicine
RU99117393A (ru) Способ проведения экстракорпорального оплодотворения
CN2301724Y (zh) 婴儿便溺监听器
HN2001000039A (es) Soluciones de acido acetisalicilico
RU2002108070A (ru) Средство "Бифилиз-С" для профилактики и лечения дисбактериоза и воспалительных заболеваний органов брюшной полости и малого таза
CN203138570U (zh) 一种新型内科用压舌板
WO2002034246A3 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
UA38329A (uk) Спосіб лікування ендометритів